Literature DB >> 8227155

Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand-receptor interaction.

M M Chaudhuri1, D Moscatelli, C Basilico.   

Abstract

The fibroblast growth factor receptor 1 (flg) contains eight acidic amino acids between the first and second immunoglobulin domain. This report examines the role of the acidic domain in the interaction of the flg receptor with its ligands. We observed a marked inhibition of binding of bFGF to the receptor when the acidic domain was completely deleted, but mutants with two and four amino acids deleted (flg delta A2 and flg delta A4, respectively) still bound the ligand. After addition of a bifunctional cross-linking reagent, cross-linked complexes (between bFGF and receptor) with the expected size were observed in cells expressing mutants lacking two or four acidic residues, but not in cells expressing mutants lacking six or eight acidic residues. Immunoprecipitation with anti-flg antibody followed by electrophoresis produced a band of 90 Kd in tunicamycin-treated cells expressing the mutant as well as the wild-type receptors, indicating that the inhibition of binding was not due to defective expression of the protein. The ability of flg delta A8 to mediate a mitogenic response to FGFs was also greatly reduced when this mutated receptor was expressed in receptor-negative cells. The effect of replacing the acidic amino acids with lysine residues was also studied. Binding of bFGF to cells transfected with a plasmid encoding a mutated protein with four amino acid substitutions was totally inhibited, but an eight amino acid substitution did not alter ligand binding to the receptor. In this case the mutation with four amino acids substitution caused a drastic impairment of protein expression. Thus the acidic domain of the FGFR-1 plays an essential role in receptor function, either because it is important for a stable protein configuration or for ligand-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227155     DOI: 10.1002/jcp.1041570202

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

2.  The Fgfr2 W290R mouse model of Crouzon syndrome.

Authors:  S-G Gong
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

3.  Vaccination with a recombinant chicken FGFR-1 bypasses immunological tolerance against self-FGFR-1 in mice.

Authors:  Shaojiang Zheng; Fengying Huang; Shaoping Zheng; Wei Wang; Hui Yin; Renliang Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Anti-angiogeneic target therapy for cancer with vaccine based on the recombinant chicken FGFR-1 in tumor-bearing mice.

Authors:  Shaoping Zheng; Junzhi Zhang; Shaojiang Zheng; Fengying Huang; Renliang Wu; Limin Cao; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

5.  Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.

Authors:  Shao-Jiang Zheng; Shao-Ping Zheng; Feng-Ying Huang; Chang-Liang Jiao; Ren-Liang Wu
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.